Skip to main content
. 2024 Dec 20;14:05037. doi: 10.7189/jogh.14.05037

Table 1.

Coverage of child routine vaccination

Urban area
Rural area
Pre-COVID-19
COVID-19 period
Pre-COVID-19
COVID-19 period
Type of vaccine
% (95% CI)
% (95% CI)
% (95% CI)
% (95% CI)
DPT1/penta1 vaccine
94.5 (88.7–97.4)
91.2 (85.6–94.8)
94.9 (90.6–97.3)
88.3 (80.2–93.3)
DPT2/penta2 vaccine
86.5 (80.6–90.8)
90.5 (85.2–94.0)
90.6 (84.1–94.7)
88.6 (81.9–93.0)
DTP3/penta3 vaccine
73.3 (66.0–79.6)
88.3 (83.1–92.1)
84.9 (76.8–90.6)
87.1 (80.3–91.8)
Measles vaccine
83.5 (73.9–90.0)
83.4 (80.0–86.3)
81.3 (71.0–88.5)
83.6 (77.1–88.5)
Dropout between DPT1 and DPT3
16.0 (11.3–22.0)
3.6 (1.7–7.6)
6.3 (3.1–12.5)
3.5 (1.9–6.4)
DPT1 vaccine taken on time (6–11 weeks)
55.0 (45.2–64.4)
58.7 (50.6–66.3)
67.4 (58.0–75.6)
52.5 (41.3–63.4)
DPT2 vaccine taken on time (10–19 weeks)
63.8 (55.1–71.6)
68.6 (62.1–74.5)
67.4 (59.2–74.7)
63.8 (55.3–71.5)
DPT3 vaccine taken on time (14–24 weeks)
49.1 (41.6–56.8)
65.2 (58.6–71.2)
65.5 (55.2–74.5)
58.9 (50.4–67.0)
Measles vaccine taken on time (6–12 months) 44.9 (36.8–53.3) 56.4 (48.1–64.4) 49.2 (38.1–60.5) 51.4 (42.1–60.6)

DPT – diphtheria, pertussis, and tetanus